Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35-55 and complete Freund adjuvant (CFA) administration.

Many data suggest involvement of inflammation in neurodegeneration. However, the exact mechanisms of this cooperation are poorly understood. We have previously shown that induction of inflammatory reaction, both before and after injury of the striatum, affects regeneration of dopaminergic neurons. In the present research we studied the role of inflammatory reaction in non-injured striatum. We used myelin oligodendrocyte glycoprotein (MOG) 35-55 in complete Freund's adjuvant (CFA) to elicit experimental autoimmune encephalomyelitis (EAE) mice model. As determined by HPLC, striatal dopamine (DA) and serotonin levels in mice treated with either MOG 35-55 in CFA or CFA alone were significantly higher compared to vehicle-treated controls on 13th day after induction. The ratio of homovanilic acid/dopamine (HVA/DA) and 3, 4 dihydroxyphenylacetic acid/dopamine (DOPAC/DA) were significantly lower in the MOG and CFA groups on 13th day, indicating decreased DA metabolism. Noradrenaline (NA) concentration did not differ between groups. Moreover, the striatal mRNA IL-1beta and TNF-alpha levels were elevated during induction phase of EAE in both groups, as determined by RT-PCR. Our data indicate regulatory connection between dopaminergic and immune systems.

• Publication year

  2007

• Venue

  Acta Neurobiologiae Experimentalis

• Publication date

  2007-12-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.55782/ane-2007-1655PMID 18320716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice

  2007cited by this paper
• Effect of endogenous catecholamines in lymphocytes on lymphocyte function.

  2005cited by this paper
• Immunization with myelin oligodendrocyte glycoprotein and complete Freund adjuvant partially protects dopaminergic neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced damage in mouse model of Parkinson's disease.

  2005cited by this paper
• Inflammation and the Degenerative Diseases of Aging

  2004cited by this paper
• Parkinson's disease

  2004cited by this paper
• Neuronal pathology in Parkinson’s disease

  2004cited by this paper
• Cellular pathology of Parkinson’s disease: astrocytes, microglia and inflammation

  2004cited by this paper
• Cytokines role in neurodegenerative events.

  2003cited by this paper
• Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease.

  2003cited by this paper
• Post intoxicative therapeutic immunization with myelin oligodendrocyte glycoproteine (MOG 35-55) suppresses spontaneous regeneration of dopaminergic neurons injured with 1-methyl-4 phenyl-1,2,3,6-tetrahydropiridine (MPTP).

  2003cited by this paper
• Involvement of inflammatory cytokines in central nervous system injury.

  2002cited by this paper
• Inflammatory changes in the substantia nigra and striatum following MPTP intoxication

  2000cited by this paper
• Activated microglial cells and complement factors are unrelated to cortical Lewy bodies

  2000cited by this paper
• MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease.

  1999cited by this paper
• Autonomic regulation of experimental autoimmune encephalomyelitis in IL-4 knockout mice.

  1999cited by this paper
• Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment.

  1999cited by this paper
• Animal models of neuroimmune interactions in inflammatory diseases.

  1999cited by this paper
• The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

  1999cited by this paper
• Ultrastructural changes in substantia nigra and striatum observed on a mouse model of Parkinson's disease induced by MPTP administration.

  1999cited by this paper
• The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system.

  1998cited by this paper
• Specificity of interleukin-1beta-induced changes in monoamine concentrations in hypothalamic nuclei: blockade by interleukin-1 receptor antagonist.

  1998cited by this paper
• Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

  1998cited by this paper
• Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model.

  1996cited by this paper
• Animal Models of Demyelination

  1996cited by this paper
• Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat

  1995cited by this paper
• Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.

  1994cited by this paper
• Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

  1994cited by this paper
• Immunological changes in the MPTP-induced Parkinson's disease mouse model.

  1993cited by this paper
• Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1.

  1992cited by this paper
• The immunological status in Parkinson's disease.

  1991cited by this paper
• Monokine production by microglial cell clones

  1989cited by this paper
• Tumor necrosis factor identified in multiple sclerosis brain

  1989cited by this paper
• Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone.

  1988cited by this paper
• Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

  1988cited by this paper
• Immunohistological analysis of macrophages in the central nervous system of Lewis rats with acute experimental allergic encephalomyelitis.

  1986cited by this paper
• Norepinephrine Depletion in the Spinal Cord Gray Matter of Rats with Experimental Allergic Encephalomyelitis

  1983cited by this paper

• The role of the stress adaptive response in multiple sclerosis.

  2025cites this paper
• Combinatorial mechanisms specify cellular location and neurotransmitter identity during regeneration of planarian neurons

  2025cites this paper
• Early life stress aggravates disease pathogenesis in mice with experimental autoimmune encephalomyelitis: Support for a two-hit hypothesis of multiple sclerosis etiology.

  2023cites this paper
• Shipment Stress in Early Life Aggravates Disease Pathogenesis in Mice with Experimental Autoimmune Encephalomyelitis: Support for a Two-Hit Hypothesis of Multiple Sclerosis Etiology

  2023cites this paper
• Thermoregulatory dynamics reveal sex-specific inflammatory responses to experimental autoimmune encephalomyelitis in mice: Implications for multiple sclerosis-induced fatigue in females

  2022cites this paper
• Hormones in experimental autoimmune encephalomyelitis (EAE) animal models

  2021cites this paper
• Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors

  2021cites this paper
• Dopaminergic Stimulation Leads B-cell In�ltration into the Central Nervous System upon Autoimmunity

  2021cites this paper
• NFKF is a synthetic fragment derived from rat hemopressin that protects mice from neurodegeneration.

  2020cites this paper
• Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity

  2020cites this paper
• Phosphodiesterase 7B1 as Therapeutic Target for Treatment of Cognitive Dysfunctions in Multiple Sclerosis

  2018influential citation
• Effects of Catecholamines on Th17 Cells in Multiple Sclerosis

  2018cites this paper
• Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis

  2018cites this paper
• Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells

  2018cites this paper
• Dopamine, T cells and multiple sclerosis (MS)

  2017cites this paper
• Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases

  2016cites this paper
• Chapter 11 - Dopamine, T Cells, and Multiple Sclerosis: Dopamine Receptors and Direct Effects on T Cells, Dopamine Production in T Cells, Abnormalities in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis, and Their Correction by Treatment

  2016cites this paper
• Multifactorial Regulation of GLH Hormones

  2016cites this paper
• Increased levels of brain serotonin correlated with MMP-9 activity and IL-4 levels resulted in severe experimental autoimmune encephalomyelitis (EAE) in obese mice.

  2016cites this paper
• Dopamine receptors D3 and D5 regulate CD4(+)T-cell activation and differentiation by modulating ERK activation and cAMP production.

  2015cites this paper
• Dopamine Receptors and Neurodegeneration.

  2015cites this paper
• The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.

  2014cites this paper
• New Aspects of Immunoregulation by Growth and Lactogenic Hormones

  2014cites this paper
• The Dopaminergic System in Autoimmune Diseases

  2014cites this paper
• Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?

  2013influential citation
• Th 17-Mediated Immunity Expressed on Dendritic Cells Potentiates Stimulation of Dopamine Receptor D 5

  2012cites this paper
• Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity

  2012cites this paper
• Immunity on Dendritic Cells Potentiates Th17-Mediated Stimulation of Dopamine Receptor D5 Expressed

  2012cites this paper
• Expression of purinergic P2X7 receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits.

  2011cites this paper
• Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.

  2011cites this paper
• Novel approaches to studying activity-dependent regulation of neurotrophins and neuropeptides in sensory pathways from orofacial tissues

  2010cites this paper